Relapsed CLL
Showing 1 - 25 of 6,017
Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)
Active, not recruiting
- Recurrent Chronic Lymphoid Leukemia
- ACY-1215
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 19, 2022
Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small
Recruiting
- Relapsed or Refractory CD19+ B-cell Lymphoma
- +2 more
- TBI-2001
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jul 26, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- (no location specified)
Nov 9, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +3 more
- Acalabrutinib
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 19, 2022
Chronic Lymphocytic Leukemia, CLL, Relapsed CLL Trial (Dose combination 1-1, dose combination 1-2, Dose combination 1-3)
Withdrawn
- Chronic Lymphocytic Leukemia
- +8 more
- Dose combination 1-1
- +5 more
- (no location specified)
Nov 1, 2021
AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)
Recruiting
- AML, Adult
- CLL1 CAR-NK cell injection
-
Hangzhou, Zhejiang, ChinaClinical research ethics committee of the first affiliated hospi
Aug 30, 2023
Chronic Lymphocytic Leukemia(CLL), Small Lymphocytic Lymphoma Trial in Hackensack (Revlimid, Azacitidine)
Terminated
- Chronic Lymphocytic Leukemia(CLL)
- Small Lymphocytic Lymphoma
-
Hackensack, New JerseyHackensack University Medical Center
Jun 24, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Acalabrutinib (Arm A)
- Acalabrutinib (Arm B)
-
Bethesda, MarylandResearch Site
Jan 3, 2023
Refractory B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Small Lymphocytic Lymphoma, Relapsed Adult ALL Trial in Houston
Recruiting
- Refractory B-Cell Non-Hodgkin Lymphoma
- +4 more
- CD19.CAR-aNKT cells
- +2 more
-
Houston, Texas
- +1 more
Aug 19, 2022
Acute Myeloid Leukemia Trial in Beijing, Tianjin (LCAR-AMDR Cells Product)
Recruiting
- Acute Myeloid Leukemia
- LCAR-AMDR Cells Product
-
Beijing, Beijing, China
- +1 more
Jan 28, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +5 more
- Nemtabrutinib
- +2 more
- (no location specified)
Jul 21, 2023
Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)
Recruiting
- Acute Myeloid Leukemia
- CLL1 and CD38 dual-target CAR-T injection
-
Kunming, Yunnan, China920th Hospital of Joint LogisticsSupport Force of People's Liber
Oct 26, 2023
Relapsed Chronic Lymphocytic Leukemia Trial in Ann Arbor (Metformin)
Recruiting
- Relapsed Chronic Lymphocytic Leukemia
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
May 11, 2022
Chronic Lymphocytic Leukemia Trial in Lebanon (BNC105P, Ibrutinib)
Completed
- Chronic Lymphocytic Leukemia
- BNC105P
- Ibrutinib
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Jan 3, 2023
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Chicago, Rochester, Cleveland (Venetoclax, Umbralisib, Ublituximab)
Terminated
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
- Venetoclax
- +3 more
-
Chicago, Illinois
- +2 more
Aug 19, 2022
Chronic Lymphocytic Leukemia (CLL) Trial in Boston (Ibrutinib, Copanlisib, Acalabrutinib)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Ibrutinib
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
May 13, 2022
AML Trial in Hangzhou (CLL1 CAR-T)
Not yet recruiting
- AML
- CLL1 CAR-T
-
Hangzhou, ChinaThe First Affiliated Hospital, Zhejiang University
Jul 17, 2022
AML Trial in Hangzhou (CLL1+CD33 CAR-T)
Not yet recruiting
- AML
- CLL1+CD33 CAR-T
-
Hangzhou, ChinaMingming Zhang Zhang
Jul 19, 2022
B-cell NHL, CLL Trial (CARCIK-CD19)
Not yet recruiting
- B-cell NHL
- CLL
- CARCIK-CD19
- (no location specified)
May 19, 2023
Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Acalabrutinib)
Active, not recruiting
- Chronic Lymphoid Leukemia
- Bendamustine
- +3 more
-
Dresden, Germany
- +16 more
Nov 8, 2022
Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving
Recruiting
- Chronic Lymphocytic Leukemia
-
Granada, Spain
- +4 more
Nov 8, 2023
B Cell NHL, CLL Trial in Sydney, Melbourne, Mount Pleasant (GB261)
Recruiting
- B Cell NHL
- CLL
- GB261
-
Sydney, New South Wales, Australia
- +4 more
Nov 16, 2022
Multiple Myeloma, CLL, Chronic Lymphocytic Leukemia Trial in Los Angeles (radiation, procedure, biological, drug)
Active, not recruiting
- Multiple Myeloma
- +4 more
- Total Body Irradiation
- +5 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 21, 2022
Chronic Lymphocytic Leukemia Trial in Washington, Hackensack (Venetoclax, Rituximab, Rituximab/Hyaluronidase Human)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Venetoclax
- +2 more
-
Washington, District of Columbia
- +1 more
Mar 14, 2022